Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
3692 Hansoh Pharmaceutical Group	HK$17.96	0.4%	41.2%	HK$106.6b	HK$23.65	PE21.2x	E6.4%	2.2%
2269 WuXi Biologics (Cayman)	HK$21.15	14.8%	19.4%	HK$86.6b	HK$21.47	PE30.8x	E16.4%	n/a
1801 Innovent Biologics	HK$35.80	8.3%	3.2%	HK$58.6b	HK$53.37	PS7.4x	E44.2%	n/a
9926 Akeso	HK$63.45	4.3%	51.4%	HK$57.0b	HK$76.67	PS28.4x	E43.8%	n/a
1177 Sino Biopharmaceutical	HK$2.97	5.3%	-0.7%	HK$54.0b	HK$4.48	PE23.6x	E12.8%	1.9%
1093 CSPC Pharmaceutical Group	HK$4.57	2.5%	-23.7%	HK$52.6b	HK$7.04	PE9.5x	E1.5%	6.9%
6990 Sichuan Kelun-Biotech Biopharmaceutical	HK$173.10	8.7%	110.8%	HK$39.3b	HK$221.79	PS19.6x	E5.1%	n/a
2268 WuXi XDC Cayman	HK$30.15	8.1%	103.7%	HK$36.1b	HK$36.43	PE56.9x	E26.9%	n/a
3320 China Resources Pharmaceutical Group	HK$5.28	1.0%	1.5%	HK$33.2b	HK$7.21	PE8.2x	E6.9%	3.4%
1877 Shanghai Junshi Biosciences	HK$11.58	5.3%	-11.3%	HK$24.9b	HK$15.61	PS6x	E45.2%	n/a
3933 United Laboratories International Holdings	HK$13.46	16.6%	83.4%	HK$24.5b	HK$12.11	PE7.9x	E5.2%	4.4%
1548 Genscript Biotech	HK$10.86	1.7%	-19.7%	HK$23.3b	HK$22.72	PS3x	E111.3%	0%
2228 XtalPi Holdings	HK$5.99	15.2%	n/a	HK$20.4b	HK$8.58	PS96.9x	E90.7%	n/a
867 China Medical System Holdings	HK$7.57	7.8%	-35.1%	HK$18.3b	HK$11.00	PE12.3x	E21.4%	5.5%
2096 Simcere Pharmaceutical Group	HK$6.80	-0.7%	27.3%	HK$16.9b	HK$9.06	PS2.5x	E71.5%	2.5%
512 Grand Pharmaceutical Group	HK$4.38	3.8%	28.4%	HK$15.3b	HK$6.63	PE6.4x	E2.3%	5.9%
1530 3SBio	HK$6.42	6.8%	9.9%	HK$15.1b	HK$8.40	PE8.5x	E16.2%	3.7%
1952 Everest Medicines	HK$41.30	2.5%	137.6%	HK$13.3b	HK$37.81	PS29.8x	E90.1%	n/a
9995 RemeGen	HK$13.90	4.7%	-23.3%	HK$13.2b	HK$25.04	PS4.6x	E51.9%	n/a
6826 Shanghai Haohai Biological Technology	HK$25.45	2.6%	3.4%	HK$12.9b	HK$42.57	PE12.7x	E16.8%	3.4%
6855 Ascentage Pharma Group International	HK$36.55	7.7%	60.7%	HK$12.4b	HK$51.15	PS12.8x	E53.7%	n/a
9969 InnoCare Pharma	HK$5.76	4.2%	13.4%	HK$12.1b	HK$8.42	PS10.6x	E27.3%	n/a
6185 CanSino Biologics	HK$30.00	6.6%	75.4%	HK$11.4b	HK$32.67	PS9.3x	E128.6%	0%
2696 Shanghai Henlius Biotech	HK$18.50	10.4%	43.9%	HK$10.1b	HK$24.59	PE13.6x	S9.9%	n/a